Search

Your search keyword '"Nguyen, Paul"' showing total 3,189 results

Search Constraints

Start Over You searched for: Author "Nguyen, Paul" Remove constraint Author: "Nguyen, Paul"
3,189 results on '"Nguyen, Paul"'

Search Results

209. Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis

212. Supplementary Figure Legend from A Single Nucleotide Polymorphism in Inflammatory Gene RNASEL Predicts Outcome after Radiation Therapy for Localized Prostate Cancer

213. Supplementary Figure Legends from Stomach-Specific Activation of Oncogenic KRAS and STAT3-Dependent Inflammation Cooperatively Promote Gastric Tumorigenesis in a Preclinical Model

214. Supplemental Figure 2. from The Landscape of Prognostic Outlier Genes in High-Risk Prostate Cancer

215. Data from Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer Types

216. Supplementary Table 2 from Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer Types

217. Supplementary Table 4 from Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer Types

218. Supplemental Figure 5. from The Landscape of Prognostic Outlier Genes in High-Risk Prostate Cancer

219. Supplementary materials from The Landscape of Prognostic Outlier Genes in High-Risk Prostate Cancer

220. Supplementary Table 1 from Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer Types

221. Supplementary Figures 1 through 7 and Supplementary Table 1 from Stomach-Specific Activation of Oncogenic KRAS and STAT3-Dependent Inflammation Cooperatively Promote Gastric Tumorigenesis in a Preclinical Model

222. Supplementary tables from Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a de novo low AR-Active Subclass in Treatment Naïve Primary Prostate Cancer

223. Data from Inflammasome Adaptor ASC Suppresses Apoptosis of Gastric Cancer Cells by an IL18-Mediated Inflammation-Independent Mechanism

224. Supplementary Table 3 from Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer Types

225. Supplementary Figures from Clinical and Genomic Implications of Luminal and Basal Subtypes Across Carcinomas

226. Supplementary Table 1 from A Single Nucleotide Polymorphism in Inflammatory Gene RNASEL Predicts Outcome after Radiation Therapy for Localized Prostate Cancer

227. Supplementary Methods from Stomach-Specific Activation of Oncogenic KRAS and STAT3-Dependent Inflammation Cooperatively Promote Gastric Tumorigenesis in a Preclinical Model

228. Supplementary Figure 1 from A Single Nucleotide Polymorphism in Inflammatory Gene RNASEL Predicts Outcome after Radiation Therapy for Localized Prostate Cancer

229. Supplemental Figure 4. from The Landscape of Prognostic Outlier Genes in High-Risk Prostate Cancer

230. Supplementary figures from Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a de novo low AR-Active Subclass in Treatment Naïve Primary Prostate Cancer

231. supp Tables from Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical Prostatectomy

232. Supplementary Figure 2 from A Single Nucleotide Polymorphism in Inflammatory Gene RNASEL Predicts Outcome after Radiation Therapy for Localized Prostate Cancer

233. Supplemental Figure 1. from The Landscape of Prognostic Outlier Genes in High-Risk Prostate Cancer

234. Supplementary Data from Inflammasome Adaptor ASC Suppresses Apoptosis of Gastric Cancer Cells by an IL18-Mediated Inflammation-Independent Mechanism

235. Sup Fig 1 from Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical Prostatectomy

236. Supplemental Figure 3. from The Landscape of Prognostic Outlier Genes in High-Risk Prostate Cancer

237. Sup Fig 2 from Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical Prostatectomy

238. Data from Stomach-Specific Activation of Oncogenic KRAS and STAT3-Dependent Inflammation Cooperatively Promote Gastric Tumorigenesis in a Preclinical Model

240. FORMULA-509: A multicenter randomized trial of post-operative salvage radiotherapy (SRT) and 6 months of GnRH agonist with or without abiraterone acetate/prednisone (AAP) and apalutamide (Apa) post-radical prostatectomy (RP).

241. Gaining metabolic insight in older men undergoing androgen deprivation therapy for prostate cancer (the ADT & Metabolism Study): Protocol of a longitudinal, observational, cohort study

248. ACR Appropriateness Criteria Renal Cell Carcinoma Staging

Catalog

Books, media, physical & digital resources